Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Science is Scopus-indexed (Q1, CiteScore 8.9), WoS SCIE, DOAJ. Published by Wiley-Blackwell.
Checked against the index lists dated .
ISSN 1347-9032Verify ISSN ↗1349-7006Verify ISSN ↗
Publisher: Wiley-Blackwell
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 68 / 428 | 84th | Q1 |
| Cancer Research | 59 / 233 | 74th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2003–present, best quartile Q1, CiteScore 8.9.
Cancer Science is Q1 in Oncology (rank 68 of 428) and Q2 in Cancer Research (rank 59 of 233), by CiteScore 2025.
Cancer Science is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.9, which places it in quartile Q1 at the 84th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.509, quartile Q1, with an H-index of 178.
The publisher lists an article processing charge of about US$2,600 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cancer Science is published by Wiley-Blackwell. Its print ISSN is 1347-9032 and its online ISSN is 1349-7006.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Cancer Science has an h-index of 187 and a 2-year mean of 4.28 citations per paper (OpenAlex). Its Scopus CiteScore is 8.9, quartile Q1. On 2-year citations it ranks #75 of 424 Scopus journals in Oncology.
Cancer Science published 345 papers in 2025; its busiest recent year was 2020 with 504. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2026), authors are most often from China (44.3%), Japan (39.9%) and United States (4.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 62 retracted papers are recorded (7.7 per 1,000 papers). The Problematic Paper Screener flags 3 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.